PCVX

Vaxcyte, Inc. · Healthcare · Market cap $8.8B

Insiders sold $5.2M net in the last 90 days ·3 sellers, 0 buyers· 9 of 9 sales under Rule 10b5-1 plans· latest Form 4 filed Nov 13, 2026

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$13.8M

reported sales (SEC code S)

Unique Insiders

5

in the rolling window

Latest filing

Nov 13, 2026

Dhaliwal Harpreet S.

Vaxcyte, Inc. (PCVX) has 54 SEC Form 4 filings (130 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Nov 13, 2026.

Inside the rolling window, 5 insiders at Vaxcyte, Inc. reported no open-market purchases and 27 open-market sales totaling $13.8M. The most active filer is EVP, Chief Scientific Ofc, COO Wassil Jim with 12 filings. Insiders have net sold $11.7M over the trailing 6 months. The most recent open-market filing is a sale of 17,000 shares by Chief Technical Ops Officer Dhaliwal Harpreet S., dated Nov 11, 2026, worth $1.2M.

  • Industry:Biotechnology
  • CEO:Grant E. Pickering
  • Employees:507
  • HQ:San Carlos, CA, US
  • IPO:2020-06-12
Source
Dhaliwal Harpreet S.First in 3 months
Sale$1.2MNov 13SEC ↗
Sale$183KNov 4SEC ↗
Sale$137KNov 4SEC ↗
Sale$1.6MOct 7SEC ↗
Cowan ElviaFirst in 6 months
Sale$1.6MOct 7SEC ↗
Sale$128KOct 2SEC ↗
Sale$84KSep 9SEC ↗
Sale$79KSep 9SEC ↗
Sale$212KSep 2SEC ↗
Dhaliwal Harpreet S.First in 7 months
Sale$935KAug 5SEC ↗
Sale$121KAug 5SEC ↗
Sale$539KAug 5SEC ↗
Sale$1.0MJul 28SEC ↗
Sale$573KJul 6SEC ↗
Sale$127KJul 6SEC ↗
Sale$1.3MJun 26SEC ↗
PICKERING GRANTFirst filing
Sale$1.2MJun 19SEC ↗
GUGGENHIME ANDREWFirst filing
Sale$530KJun 19SEC ↗
Sale$111KJun 3SEC ↗
Sale$128KMay 1SEC ↗
Sale$180KApr 8SEC ↗
Sale$131KApr 3SEC ↗
Sale$105KMar 18SEC ↗
Sale$146KMar 11SEC ↗
Wassil JimFirst filing
Sale$435KMar 11SEC ↗
Showing 1–25 of 27
1 / 2

Earnings: last 7 quarters

EstimatedActual

Congress trading PCVX 8 all-time

  • DRep. Gilbert CisnerosPurchase$1,001 - $15,0002026-07-16
  • DRep. Gilbert Ray CisnerosPurchase$1,001 - $15,0002026-07-15
  • DRep. Gilbert CisnerosPurchase$1,001 - $15,0002026-05-12
  • DRep. Gilbert CisnerosPurchase$1,001 - $15,0002026-05-13
  • DRep. Gilbert Ray CisnerosPurchase$1,001 - $15,0002026-05-12
  • DRep. Gilbert Ray CisnerosPurchase$1,001 - $15,0002026-05-13

STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.

Frequently asked questions

How many SEC Form 4 insider filings does PCVX have?

Vaxcyte, Inc. (PCVX) has 54 SEC Form 4 filings (130 transaction rows) in the rolling 365-day window, disclosed by 5 distinct insiders. Most recent filing: Nov 13, 2026.

When was the most recent SEC Form 4 filing for PCVX?

The most recent Form 4 filing for PCVX on Tracefour is dated Nov 13, 2026.

Who is the most active insider at PCVX?

The most active SEC Form 4 filer at PCVX in the rolling window is EVP, Chief Scientific Ofc, COO Wassil Jim, with 12 filings.

What is the net insider flow at PCVX over the last 6 months?

Over the trailing 180 days, insiders at PCVX have net sold $11.7M based on SEC Form 4 disclosures.

What is the total insider buy and sell value at PCVX in the current window?

Inside the rolling window, insiders at PCVX bought $0 and sold $13.8M based on SEC Form 4 filings.

Can I get alerts for PCVX insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Vaxcyte, Inc. (PCVX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

Vaxcyte, Inc. is in the Healthcare sector.